Fayed, Alaa E. http://orcid.org/0000-0003-2634-3880
Menten, Martin J.
Kreitner, Linus
Paetzold, Johannes C.
Rueckert, Daniel http://orcid.org/0000-0002-5683-5889
Bassily, Sherry M.
Fikry, Ramy R.
Hagag, Ahmed M. http://orcid.org/0000-0002-3372-7885
Sivaprasad, Sobha
Article History
Received: 11 November 2023
Revised: 8 February 2024
Accepted: 6 March 2024
First Online: 21 March 2024
Competing interests
: AF: None, MM: None, LK: None, JCP: None, DR: None, SB: None, AH: Boehringer Ingelheim Ltd (E), SS: Bayer (F), Novartis (F), Abbvie (F), Roche (F), Boehringer Ingelheim (F), Optos (F), EyeBiotech (F), Biogen (F)Apellis (F), Janssen Pharmaceuticals (F), Ocular Therapeutix (F), OcuTerra (F). SS is a member of the Eye Editorial Board.